This is a Validated Antibody Database (VAD) review about human BIRC7, based on 8 published articles (read how Labome selects the articles), using BIRC7 antibody in all methods. It is aimed to help Labome visitors find the most suited BIRC7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BIRC7 synonym: KIAP; LIVIN; ML-IAP; MLIAP; RNF50

Santa Cruz Biotechnology
mouse monoclonal (4H196)
  • western blot; human; fig 1
In order to investigate stabilization of XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma via USP9X, Santa Cruz Biotechnology BIRC7 antibody (Santa Cruz, sc-71592) was used in western blot on human samples (fig 1). EMBO Mol Med (2016) ncbi
Active Motif
mouse monoclonal (88C570)
  • immunohistochemistry; human
Active Motif BIRC7 antibody (Active Motif, 40958) was used in immunohistochemistry on human samples . PLoS ONE (2010) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D61D1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology BIRC7 antibody (CST, 5471) was used in immunohistochemistry - paraffin section on human samples (fig 1a) and in western blot on human samples (fig 2a). Am J Cancer Res (2020) ncbi
domestic rabbit monoclonal (D61D1)
  • western blot; human; 1:1500; loading ...; fig 2b
Cell Signaling Technology BIRC7 antibody (Cell Signaling, 5471) was used in western blot on human samples at 1:1500 (fig 2b). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (D61D1)
  • western blot; human; fig 3
Cell Signaling Technology BIRC7 antibody (CST, 5471) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D61D1)
  • immunohistochemistry; human; 1:100; fig 4
In order to demonstrate that the p53-R248Q mutant targets the proteasome activator REGgamma to promote endometrial cancer progression, Cell Signaling Technology BIRC7 antibody (Cell Signaling Technology, 5471) was used in immunohistochemistry on human samples at 1:100 (fig 4). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (D61D1)
  • western blot; human; fig 1
Cell Signaling Technology BIRC7 antibody (Cell Signaling, 5471) was used in western blot on human samples (fig 1). Oncogene (2015) ncbi
domestic rabbit monoclonal (D61D1)
  • western blot; human; fig 5
In order to study targeting sEcad for treatment of breast cancer, Cell Signaling Technology BIRC7 antibody (Cell Signaling, 5471) was used in western blot on human samples (fig 5). Mol Carcinog (2014) ncbi
Articles Reviewed
  1. Liu K, Yu Q, Li H, Xie C, Wu Y, Ma D, et al. BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy. Am J Cancer Res. 2020;10:78-94 pubmed
  2. Engel K, Rudelius M, Slawska J, Jacobs L, Ahangarian Abhari B, Altmann B, et al. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO Mol Med. 2016;8:851-62 pubmed publisher
  3. Chen X, Dong X, Gao H, Jiang Y, Jin Y, Chang Y, et al. Suppression of HSP27 increases the anti‑tumor effects of quercetin in human leukemia U937 cells. Mol Med Rep. 2016;13:689-96 pubmed publisher
  4. Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 2015;6:24075-91 pubmed
  5. Wang H, Bao W, Jiang F, Che Q, Chen Z, Wang F, et al. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ. Cancer Lett. 2015;360:269-79 pubmed publisher
  6. Gilan O, Diesch J, Amalia M, Jastrzebski K, Chueh A, Verrills N, et al. PR55?-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity. Oncogene. 2015;34:1333-9 pubmed publisher
  7. Brouxhon S, Kyrkanides S, Teng X, O Banion M, Clarke R, Byers S, et al. Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers. Mol Carcinog. 2014;53:893-906 pubmed publisher
  8. Ruckert F, Dawelbait G, Winter C, Hartmann A, Denz A, Ammerpohl O, et al. Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis. PLoS ONE. 2010;5:e12243 pubmed publisher